EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies …

…, F Lioté, G McCarthy, P Netter, G Nuki… - Annals of the …, 2006 - ard.bmj.com
Objective: To develop evidence based recommendations for the management of gout. Methods:
The multidisciplinary guideline development group comprised 19 rheumatologists and …

[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research …

W Zhang, G Nuki, RW Moskowitz, S Abramson… - Osteoarthritis and …, 2010 - Elsevier
OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 January …

2016 updated EULAR evidence-based recommendations for the management of gout

…, H Janssens, F Lioté, C Mallen, G Nuki… - Annals of the …, 2017 - ard.bmj.com
Background New drugs and new evidence concerning the use of established treatments have
become available since the publication of the first European League Against Rheumatism …

[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

W Zhang, RW Moskowitz, G Nuki, S Abramson… - Osteoarthritis and …, 2008 - Elsevier
… Acetaminophen (up to 4 g/day) can be an effective initial oral analgesic for treatment of mild
to moderate pain in patients with knee or hip OA. In the absence of an adequate response, …

[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of …

W Zhang, RW Moskowitz, G Nuki, S Abramson… - Osteoarthritis and …, 2007 - Elsevier
PURPOSE: As a prelude to developing updated, evidence-based, international consensus
recommendations for the management of hip and knee osteoarthritis (OA), the Osteoarthritis …

A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis

…, R Prayson, RA Luqmani, G Nuki… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate treatment with methotrexate (MTX) in patients with newly diagnosed
giant cell arteritis (GCA) to determine if MTX reduces GCA relapses and cumulative …

[PDF][PDF] 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

…, F Lioté, RP Naden, G Nuki… - Arthritis & …, 2015 - Wiley Online Library
Objective Existing criteria for the classification of gout have suboptimal sensitivity and/or
specificity, and were developed at a time when advanced imaging was not available. The …

Treatment of rheumatoid arthritis with recombinant human interleukin‐1 receptor antagonist

…, M Doherty, Z Domljan, P Emery, G Nuki… - Arthritis & …, 1998 - Wiley Online Library
Objective To evaluate the efficacy and safety of interleukin‐1 receptor antagonist (IL‐1Ra)
in patients with rheumatoid arthritis (RA). Methods Patients with active and severe RA (…

Experimentally-induced osteoarthritis in the dog.

MJ Pond, G Nuki - Annals of the rheumatic diseases, 1973 - ncbi.nlm.nih.gov
Discussion PROF. DL GARDNER (Belfast) Dr. Pond and his colleagues are not wholely
accurate in stating that no other models exist for the reproduction of osteoarthrosis. Division of …

British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout

…, J Seckl, A Hingorani, R Jaques, G Nuki - …, 2007 - academic.oup.com
… George Nuki on behalf of the British Society for Rheumatology and British Health
Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG) …